At the American Diabetes Association’s (ADA) annual meeting in New Orleans last week, five prominent members of the diabetes research community were forcibly removed after distributing an editorial critical of the Trump administration’s approach to scientific funding and research. The incident has sparked intensified debate over political interference in science and raised questions about the role of professional organizations amid increasing government pressure.
The five scientists—four former ADA presidents and Steven Kahn, editor of the ADA’s journal Diabetes Care—were handing out printed copies of an editorial sharply criticizing recent reductions in federal research funding and restrictions on scientific inquiry tied to political agendas. According to Kahn, the editorial was printed at his personal expense and intended to inform attendees about threats to biomedical research. Security personnel and New Orleans police removed the scientists from the conference hall, confiscated their materials, revoked their badges, and threatened arrest upon reentry.
The ADA defended its actions by citing internal policies requiring a strictly nonpartisan environment at organizational events and suggested the scientists’ distribution of the editorial violated IRS regulations applicable to nonprofit organizations. The association announced it would conduct an independent review of the incident following mounting backlash. Among critics was Massachusetts General Hospital’s David Nathan, who led an open letter condemning ADA’s conduct; it had gathered over 6,400 signatures by mid-June.
Experts argue that the episode highlights a broader crisis within U.S. biomedical research, intensified by the Trump administration’s policies. Peter Hotez of Baylor College of Medicine characterized the controversy as part of a systematic effort dubbed MAHA (“Make America Healthy Again”) aimed at undermining independent academic research and replacing it with ideologically driven pseudoscience. His concerns echo recent proposals by the Office of Management and Budget (OMB) to increase political oversight of scientific grant applications, restricting funding for projects supporting diversity, equity, inclusion, or research challenging traditional concepts of sex and gender.
The OMB’s proposal, led by Russell Vought, has prompted strong criticism from leading scientific organizations. The American Association for the Advancement of Science labeled it a “brazen power grab,” warning that it threatens the future of scientific innovation and national well-being.
The broader context underscores the economic and public health consequences of diminished scientific investment. The dismantling of U.S. Agency for International Development programs, including pest monitoring efforts, has allowed agricultural threats like the New World screwworm to resurface in Texas, risking billions in economic damage. Public health setbacks are also evident, with measles cases rising sharply in 2026 amid anti-vaccine rhetoric promoted by Health and Human Services Secretary Robert F. Kennedy Jr., increasing response costs for local health authorities.
Proposed cuts to key scientific agencies are substantial: a 61% reduction to the National Science Foundation, 40% to the National Institutes of Health, and 44% to the Centers for Disease Control and Prevention. Analyses suggest these reductions could shrink the U.S. economy by $1 trillion compared to sustaining 2025 research and development funding levels. Additionally, numerous NIH-funded clinical trials have been terminated, affecting tens of thousands of study participants.
In response to these trends, the Diabetes Care editorial and the actions by Kahn and colleagues represent a call to action, emphasizing that scientific inquiry should not be subject to political interference or fear of backlash. The editorial warned that ongoing funding cuts threaten to drive researchers away and undermine future progress in diabetes and other diseases.
The whistleblower scientists sought an apology from the ADA, which was issued by CEO Charles Henderson, who acknowledged the community’s concerns and expressed regret over the events. Meanwhile, ADA President-elect Jennifer Green of Duke University and scientific sessions chair Mark Atkinson of the University of Florida have resigned, though their involvement in the incident remains unclear.
The episode at the ADA meeting serves as a cautionary example of increasing tensions between scientific independence and political influence in the United States. It also raises urgent questions about how professional institutions will navigate these challenges moving forward.